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Mortality among children and young people who survive cancer in Northern Ireland
Dr Anna Gavin & Dr David Donnelly,
N. Ireland Cancer Registry 
21 years (1993-2013) of cancer incidence data (ICD10 C00-C97)
including non-malignant brain tumours ( ICD 10- D32, D33.0-33.4,
D35.2-35.4, D42, D43.0-43.4, D44.3-44.5) from the N. Ireland Cancer
Registry for persons aged 0-24 years at diagnosis was analysed using
Joinpoint regression for trends and the Kaplan Meier method for
survival analysis up to end of 2013 with excess mortality calculated at
one and five years after first cancer diagnosis using standardised
mortality ratios with expected mortality based on person years.
While survival rates for childhood cancers are excellent it is known that
these patients have an increased risk of death from disease recurrence
and other causes. In Northern Ireland approximately 125 children and
young people aged 0-24 are diagnosed with cancer for the first time
each year. Long term survival for these people is generally good, with
four out of five patients still alive five years from their diagnosis. We
investigate patterns, trends and survival of cancers in children and
young adults in N. Ireland.
2633 children and young people were diagnosed with cancer, 1386
(52.6%) male and 1247 female with 1139 (43.3%) aged 0-14. While
trends increased over time they did not reach statistical significance
except in the 15-24 age group for males and females combined. The
most common cancers for age 0-14 were brain, eye and central
nervous system and leukaemia with skin (including non-melanoma
skin) the most common in the 15-24 age group (See Figure). 59
patients (2.2%) had a record of a second cancer. Survival was high at
90.7% after 1 year, better among females than males and similar for
older and younger age groups. Although mortality in children is low
overall, there was an excess mortality among cancer survivors of 24.7%
(22.0-27.5; p<0.001) at one year ( table 1) and 7.3% (5.5-9.2;p<0.001)
for those who survived 5 years ( table 2). For one year survivors
mortality from causes other than the primary cancer was double that of
the background level (SMR=2.2 (1.3-3.0), p=0.005). Excess mortality
was also higher among 5 year survivors (SMR=1.5 (0.6-2.3), p=0.269)
however this was not statistically significant.
While survival from childhood cancers is excellent this work in common
with larger studies highlights the need for ongoing monitoring of cancer
survivors.
Introduction: Methods:
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Table 2: Excess mortality among five year survivors aged 0-24 at diagnosis diagnosed with 
cancer during 1993-2008:  
Cause of death Observed 
deaths 
Expected 
deaths 
Mortality 
rate 
Standardised mortality 
ratio (95% CI) 
Absolute excess risk 
(95% CI) 
Male 
      
   All causes 33 5.5 576.9 6.0 (4.0, 8.1) p<0.001 480.9 (284.6, 677.2) 
   First cancer 28 0.0 489.5   489.5 (308.6, 670.3) 
   All but first cancer 5 5.5 87.4 0.9 (0.1, 1.7) p=0.826 -8.6 (-85.2, 68.0) 
  
      
Female 
      
   All causes 27 2.7 471.5 10.1 (6.3, 13.9) p<0.001 424.7 (247.2, 602.1) 
   First cancer 20 0.0 349.3   349.3 (196.5, 502.1) 
   All but first cancer 7 2.7 122.3 2.6 (0.7, 4.5) p=0.103 75.4 (-15.1, 165.9) 
  
      
Both sexes 
      
   All causes 60 8.2 524.2 7.3 (5.5, 9.2) p<0.001 452.8 (320.5, 585.1) 
   First cancer 48 0.0 419.3   419.3 (301.0, 537.7) 
   All but first cancer 12 8.2 104.8 1.5 (0.6, 2.3) p=0.269 33.4 (-25.9, 92.7) 
     Second cancer 5 1.5 43.7 3.2 (0.4, 6.1) p=0.122 30.2 (-8.1, 68.5) 
     Non-cancer 7 6.6 61.2 1.1 (0.3, 1.8) p=0.889 3.2 (-42.1, 48.5) 
        External causes 4 3.7 34.9 1.1 (0.0, 2.1) p=0.894 2.3 (-31.9, 36.6) 
Note: 14 patients who died but had no recorded cause of death were assumed to have died from their first cancer 
 Table 1. Excess mortality among one-year survivors aged 0-24 at diagnosis diagnosed with 
cancer during 1993-2008:  
Cause of death Observed 
deaths 
Expected 
deaths 
Mortality 
rate 
Standardised mortality ratio 
(95% CI) 
Absolute excess risk 
(95% CI) 
Male 
      
   All causes 188 8.5 1,976.4 22.1 (18.9, 25.3) p<0.0011 1887.0 (1607.3, 2166.7) 
   First cancer 174 0.0 1,829.2 - - 1829.2 (1559.9, 2098.6) 
   All but first cancer 14 8.5 147.2 1.6 (0.8, 2.5) p=0.142 57.8 (-19.3, 134.8) 
      Second cancer 3 1.0 31.5 2.9 (-0.4, 6.2) p=0.257 20.6 (-15.1, 56.3) 
      Non-cancer 11 7.5 115.6 1.5 (0.6, 2.3) p=0.287 37.1 (-31.2, 105.4) 
  
      
Female 
      
   All causes 121 4.0 1,295.3 30.4 (24.9, 35.8) p<0.001 1252.7 (1023.3, 1482.0) 
   First cancer 108 0.0 1,156.2 - - 1156.2 (939.4, 1372.9) 
   All but first cancer 13 4.0 139.2 3.3 (1.5, 5.0) p=0.012 96.5 (20.9, 172.1) 
     Second cancer 4 1.2 42.8 3.3 (0.1, 6.5) p=0.166 29.7 (-12.3, 71.6) 
     Non-cancer 9 2.8 96.3 3.3 (1.1, 5.4) p=0.037 66.8 (3.9, 129.7) 
  
      
Both sexes 
      
   All causes 309 12.5 1,639.0 24.7 (22.0, 27.5) p<0.001 1572.7 (1391.5, 1754.0) 
   First cancer 282 0.0 1,495.8 - - 1495.8 (1322.5, 1669.0) 
   All but first cancer 27 12.5 143.2 2.2 (1.3, 3.0) p=0.005 77.0 (23.0, 130.9) 
     Second cancer 7 2.3 37.1 3.1 (0.8, 5.4) p=0.073 25.1 (-2.4, 52.6) 
     Non-cancer 20 10.2 106.1 2.0 (1.1, 2.8) p=0.029 51.8 (5.4, 98.3) 
       Circulatory disease 4 1.3 21.2 3.1 (0.1, 6.1) p=0.178 14.3 (-6.5, 35.1) 
       Congenital 
       malformations 4 0.2 21.2 16.2 (0.3, 32.1) p=0.061 19.9 (-0.9, 40.7) 
       External causes 7 5.9 37.1 1.2 (0.3, 2.1) p=0.667 6.0 (-21.5, 33.5) 
Note: 14 patients who died but had no recorded cause of death were assumed to have died from their first cancer 
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